Technologies Available for Licensing
A PLASMODIUM VIVAX HYBRID CIRCUMSPOROZOITE PROTEIN AND VACCINE
Described in this application is a synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax.
Docket:WRAIR 2005-12
Publication/Issued No.:8,697,856
Publication/Issue Date:2014-04-15
Categories: Vaccine
More Detail:Visit USPTO.GOV
Lab:WRAIR
Inventor(s):YADAVA, A; OCKENHOUSE, C.